Literature DB >> 8627445

Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiency.

M Kaplan1, F F Rubaltelli, C Hammerman, M T Vilei, C Leiter, A Abramov, M Muraca.   

Abstract

We used a system capable of measuring conjugated bilirubin and its monoconjugated and diconjugated fractions in serum to assess bilirubin conjugation in 29 glucose-6-phosphate dehydrogenase (G6PD)-deficient, term, male newborn infants and 35 control subjects; all had serum bilirubin levels > or = 256 mumol/L (15 mg/dI). The median value for diconjugated bilirubin was lower in the G6PD-deficient neonates than in control subjects (0.06 (range 0.00 to 1.84) vs 0.21 (range 0.00 to 1.02) mumol/L, p = 0.006). Diglucuronide was undetectable in 11 (38.9%) of the G6PD-deficient infants versus 3 (8.6%) of the control subjects (p = 0.015). These findings imply a partial defect of bilirubin conjugation not previously demonstrated in G6PD-deficient newborn infants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627445     DOI: 10.1016/s0022-3476(96)80138-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.

Authors:  M Kaplan; P Renbaum; E Levy-Lahad; C Hammerman; A Lahad; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 2.  Prevention of Kernicterus in South Asia: role of neonatal G6PD deficiency and its identification.

Authors:  Yassar H Arain; Vinod K Bhutani
Journal:  Indian J Pediatr       Date:  2014-04-26       Impact factor: 1.967

3.  Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity.

Authors:  M Kaplan; M Muraca; H J Vreman; C Hammerman; M T Vilei; F F Rubaltelli; D K Stevenson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

4.  Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.

Authors:  Sophie Uyoga; Alex W Macharia; Carolyne M Ndila; Gideon Nyutu; Mohammed Shebe; Kennedy O Awuondo; Neema Mturi; Norbert Peshu; Benjamin Tsofa; J Anthony G Scott; Kathryn Maitland; Thomas N Williams
Journal:  Blood Adv       Date:  2020-12-08

5.  Glucose-6-phosphate dehydrogenase deficiency in neonates.

Authors:  R Iranpour; M R Akbar; I Haghshenas
Journal:  Indian J Pediatr       Date:  2003-11       Impact factor: 1.967

Review 6.  Current drug treatment options in neonatal hyperbilirubinaemia and the prevention of kernicterus.

Authors:  F F Rubaltelli
Journal:  Drugs       Date:  1998-07       Impact factor: 9.546

7.  Glyphosate, pathways to modern diseases III: Manganese, neurological diseases, and associated pathologies.

Authors:  Anthony Samsel; Stephanie Seneff
Journal:  Surg Neurol Int       Date:  2015-03-24

Review 8.  Pleiotropic Outcomes of Glyphosate Exposure: From Organ Damage to Effects on Inflammation, Cancer, Reproduction and Development.

Authors:  Marianna Marino; Elena Mele; Andrea Viggiano; Stefania Lucia Nori; Rosaria Meccariello; Antonietta Santoro
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.